Recombinant production platform for Group A Streptococcus glycoconjugate vaccines
Group A Streptococcus (Strep A) is a human-exclusive bacterial pathogen killing annually more than 500,000 patients, and no current licensed vaccin…
Category: Conjugate vaccines
Product and trial design considerations on the path towards a vaccine to combat opioid overdose
Opioid overdose deaths are an evolving public health emergency in the United States. Recent advancements in drug conjugate vaccine design and adjuv…